BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ma Z, Guo D, Wang Q, Liu P, Xiao Y, Wu P, Wang Y, Chen B, Liu Z, Liu Q. Lgr5-mediated p53 Repression through PDCD5 leads to doxorubicin resistance in Hepatocellular Carcinoma. Theranostics 2019;9:2967-83. [PMID: 31244936 DOI: 10.7150/thno.30562] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Cao H, Chen X, Wang Z, Wang L, Xia Q, Zhang W. The role of MDM2-p53 axis dysfunction in the hepatocellular carcinoma transformation. Cell Death Discov 2020;6:53. [PMID: 32595984 DOI: 10.1038/s41420-020-0287-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
2 Tang J, Sui CJ, Wang DF, Lu XY, Luo GJ, Zhao Q, Lian QY, Jeong S, Lin XM, Zhu YJ, Zheng B, Wu R, Wang Q, Liu XL, Liu JF, Xia Q, Wu G, Gu J, Wang HY, Chen L. Targeted sequencing reveals the mutational landscape responsible for sorafenib therapy in advanced hepatocellular carcinoma. Theranostics 2020;10:5384-97. [PMID: 32373219 DOI: 10.7150/thno.41616] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
3 Chen H, Wang X, Chen Y, Han J, Kong D, Zhu M, Fu X, Wu Y. Pten loss in Lgr5+ hair follicle stem cells promotes SCC development. Theranostics 2019;9:8321-31. [PMID: 31754399 DOI: 10.7150/thno.35467] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
4 Mirzaei S, Abadi AJ, Gholami MH, Hashemi F, Zabolian A, Hushmandi K, Zarrabi A, Entezari M, Aref AR, Khan H, Ashrafizadeh M, Samarghandian S. The involvement of epithelial-to-mesenchymal transition in doxorubicin resistance: Possible molecular targets. Eur J Pharmacol 2021;908:174344. [PMID: 34270987 DOI: 10.1016/j.ejphar.2021.174344] [Reference Citation Analysis]
5 Ha F, Li N, Long C, Zheng P, Hu G, Jia G, Wang T. The Effect of Global DNA Methylation on PDCD5 Expression in the PBMC of Occupational Chromate Exposed Workers. J Occup Environ Med 2021;63:600-8. [PMID: 34184653 DOI: 10.1097/JOM.0000000000002192] [Reference Citation Analysis]
6 Greither T, Koser F, Holzhausen HJ, Güttler A, Würl P, Kappler M, Wach S, Taubert H. MiR-155-5p and MiR-203a-3p Are Prognostic Factors in Soft Tissue Sarcoma. Cancers (Basel) 2020;12:E2254. [PMID: 32806571 DOI: 10.3390/cancers12082254] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
7 Naz A, Zhang S, An L, Song Z, Zi Z, Wu J, Lai S, Mazhar H, Xu M, Chen Y, Zou Y, He L, Zhu H. Muscle-specific programmed cell death 5 deletion attenuates cardiac aging. Int J Cardiol 2021;345:98-104. [PMID: 34710491 DOI: 10.1016/j.ijcard.2021.10.142] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Schulte LA, López-Gil JC, Sainz B Jr, Hermann PC. The Cancer Stem Cell in Hepatocellular Carcinoma. Cancers (Basel) 2020;12:E684. [PMID: 32183251 DOI: 10.3390/cancers12030684] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
9 Farzaneh Z, Vosough M, Agarwal T, Farzaneh M. Critical signaling pathways governing hepatocellular carcinoma behavior; small molecule-based approaches. Cancer Cell Int 2021;21:208. [PMID: 33849569 DOI: 10.1186/s12935-021-01924-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Nia A, Dhanasekaran R. Genomic Landscape of HCC. Curr Hepatol Rep 2020;19:448-61. [PMID: 33816052 DOI: 10.1007/s11901-020-00553-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
11 Shi Z, Yao J, Ma X, Xu D, Ming G. CUL5-mediated Visfatin (NAMPT) degradation blocks endothelial proliferation and angiogenesis via the MAPK/PI3K-AKT signaling. J Cardiovasc Pharmacol 2021. [PMID: 34596622 DOI: 10.1097/FJC.0000000000001146] [Reference Citation Analysis]